The impact of over-the-counter vitamin D supplements on vitamin D and parathyroid hormone levels in chronic kidney disease

Clinical Nephrology

Volumn 65, Issue 2, 2006, Pages 91-96

  Sekkarie, M ^a,b  

^a Nephrology and Hypertension Associates   (United States)

^b NONE   (United States)

Author keywords

Chronic kidney disease; Secondary hyperparathyroidism; Vitamin D

Indexed keywords

CALCIUM; ERGOCALCIFEROL; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D;

AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL PROTOCOL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERPARATHYROIDISM; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PRIMARY PREVENTION; STATISTICAL ANALYSIS; VITAMIN SUPPLEMENTATION;

EID: 32444447064     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP65091     Document Type: Article

References (14)

1. Block G, Port FK 2003 Calcium phosphate metabolism and cardiovascular disease in patients with chronic kidney disease. Semin Dial 16: 140-147
2. Chertow GM, Burke SK, Raggi P 2002 Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62: 245-252
3. Coburn JW, Elangovan L 1998 Prevention of metabolic bone disease in the pre-end-stage renal disease setting. J Am Soc Nephrol 9: 71-77
4. Couttenye MM, D'Haese PC, Verschoren WJ, Behets GJ, Schrooten I, De Broe ME 1999 Low bone turnover in patients with renal failure. Kidney Int 73: S70-S76
5. 3 in the osteomalacia of chronic renal failure. Clin Sci Mol Med 52: 499-508
6. Fajtova VT, Sayegh MH, Hickey N, Aliabadi P, Lazarus JM, LeBoff MS 1995 Intact parathyroid hormone levels in renal insufficiency. Calcif Tissue Int 57: 329-335
7. Holick MF 2005 Vitamin D deficiency in CKD: why should we care? Am J Kidney Dis 45: 1119-1121
8. Holick MF 2004a Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79: 362-371
9. Holick MF 2004b Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80: 1678-1688
10. Ishimura E, Nishizawa Y, Inaba M 1999 Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int 55: 1019-1027
11. LaClair RE, Hellman RN, Karp SN 2005 Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis 45: 1026-1033
12. National Kidney Foundation K/DOQI 2003 Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42: S1-201
13. 3. Cancer Epidemiol Biomarkers Prev 7: 391-395
14. Veith R 1999 Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69: 842-856